73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Dienstag, 31.05.2022
Maligne Gliome I/Malignant gliomas I
Meeting Abstract
(V220)
[Volltext]
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma
Mijderwijk HJ, Nieboer D, Incekara F, Berger K, Steyerberg E, van den Bent MJ, Reifenberger G, Hänggi D, Smits M, Senft CA, Rapp M, Sabel M, Voss M, Forster MT, Kamp MA[Volltext]
Meeting Abstract
(V221)
[Volltext]
The intra-tumoral heterogeneity in glioblastoma – a limitation for prognostic value of epigenetic markers?
Sippl C, Saenz A, Teping F, Trenkpohl V, Ketter R, Kim YJ, Oertel J, Urbschat S[Volltext]
Meeting Abstract
(V222)
[Volltext]
The clinical frailty scale as predictor of overall survival after resection of high-grade glioma
Klingenschmid J, Krigers A, Pinggera D, Kerschbaumer J, Freyschlag CF, Thomé C[Volltext]
Meeting Abstract
(V223)
[Volltext]
Genomic characterisation of IDH-Wildtype Glioblastoma in different age groups
Richter S, Stasik S, Schackert G, Thiede C, Krex D, Juratli T[Volltext]
Meeting Abstract
(V225)
[Volltext]
A role for resective surgery in the treatment of multicentric/multifocal glioblastoma
Dimov D, Simon M, Grote A, Berger B, Coras R, Brainman D[Volltext]
Meeting Abstract
(V226)
[Volltext]
Diagnostic discrepancy between MRI-based non-GBM like tumours and molecular GBM-confirmation based on the 2021-WHO-classification of CNS tumours
Bytyqi F, Lotfinia M, Koch A, Sergejew F, Spüntrup E, Walter J, Walter-Diessars M[Volltext]
Meeting Abstract
(V227)
[Volltext]
Impact of antiepileptic drug treatment on 5-aminolevulinic acid fluorescence expression in IDH-1 wild-type glioblastoma
Wach J, Güresir Á, Hamed M, Vatter H, Herrlinger U, Becker A, Güresir E[Volltext]
Meeting Abstract
(V228)
[Volltext]
First results of the TIGER study – treatment decision and quality of life of glioblastoma patients during TTFields therapy in routine clinical care
Bähr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M[Volltext]
